TRAVERE THERAPEUTICS, INC. Accrued Liabilities (Deprecated 2009-01-31)
TRAVERE THERAPEUTICS, INC. (TVTX) had Accrued Liabilities (Deprecated 2009-01-31) of $32.67 thousand as of 2012-08-31, per its 10-Q filed 2012-10-10.
Discontinued › Notes › Payables and Accruals
us-gaap:AccruedLiabilities · last filed 2012-10-10
- 2012-08-31: Accrued Liabilities (Deprecated 2009-01-31) $32.67K.
- 2012-05-31: Accrued Liabilities (Deprecated 2009-01-31) $32.17K.
- 2012-02-29: Accrued Liabilities (Deprecated 2009-01-31) $31.67K.
| Period end | Accrued Liabilities (Deprecated 2009-01-31) |
|---|---|
| 2012-08-31 | $32.67K 10-Q · filed 2012-10-10 |
| 2012-05-31 | $32.17K 10-Q · filed 2012-08-08 |
| 2012-02-29 | $31.67K 10-Q · filed 2012-10-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |